Immune clues in the ICU could predict who lives or dies

NCT ID NCT07345169

First seen Jan 31, 2026 · Last updated Jun 23, 2026 · Updated 19 times

Summary

This study looks at how the immune system and inflammation affect recovery in 540 adults admitted to intensive care. Researchers will take extra blood samples to measure immune cells and inflammatory markers. The goal is to build models that predict survival and infections over one year.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AP-HP Laribosière Hospital, Anesthesia and Critical Care Departement

    RECRUITING

    Paris, 75010, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors better predict which ICU patients are at higher risk of death or infection, leading to more personalized care.

What could go wrong

This is an observational study, not a treatment trial. It may identify patterns but cannot prove cause and effect. Results may not change current care.

Conditions

The condition(s) this trial relates to.

Critical Illness Inflammation nosocomial infection Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.